New guidelines on duration of dual antiplatelet therapy in patients with coronary artery disease: what's the novelty?

被引：0
|
作者：
Helft, Gerard [1 ]
机构：
[1] Pierre & Marie Curie Univ, Pitie Salpetriere Hosp, AP HP, Inst Cardiol,Inst Cardiometab & Nutr, Paris, France
来源：
JOURNAL OF THORACIC DISEASE | 2016年 / 8卷 / 10期
关键词：
ELUTING STENT IMPLANTATION; TASK-FORCE; ASSOCIATION; EFFICACY; SOCIETY; TRIAL;
D O I：
10.21037/jtd.2016.10.98
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1301 / E1303
页数：3
相关论文
共 50 条
  • [1] Focused Update on Duration of Dual Antiplatelet Therapy for Patients With Coronary Artery Disease
    Mauri, Laura
    Smith, Sidney C., Jr.
    JAMA CARDIOLOGY, 2016, 1 (06) : 733 - 734
  • [2] Optimal duration of dual antiplatelet therapy for coronary artery disease
    Kikkert, W. J.
    Damman, P.
    NETHERLANDS HEART JOURNAL, 2018, 26 (06) : 321 - 333
  • [3] Optimal duration of dual antiplatelet therapy for coronary artery disease
    W. J. Kikkert
    P. Damman
    Netherlands Heart Journal, 2018, 26 : 321 - 333
  • [4] Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article
    Alex D. Moseley
    Fareed M. Collado
    Annabelle Santos Volgman
    Gary L. Schaer
    R. Jeffrey Snell
    Current Atherosclerosis Reports, 2016, 18
  • [5] Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article
    Moseley, Alex D.
    Collado, Fareed M.
    Volgman, Annabelle Santos
    Schaer, Gary L.
    Snell, R. Jeffrey
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (07)
  • [6] Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
    Bittl, John A.
    Baber, Usman
    Bradley, Steven M.
    Wijeysundera, Duminda N.
    Halperin, Jonathan L.
    Levine, Glenn N.
    Al-Khatib, Sana M.
    Birtcher, Kim K.
    Bozkurt, Biykem
    Brindis, Ralph G.
    Cigarroa, Joaquin E.
    Curtis, Lesley H.
    Fleisher, Lee A.
    Gentile, Federico
    Gidding, Samuel
    Hlatky, Mark A.
    Ikonomidis, John S.
    Joglar, Jose A.
    Pressler, Susan J.
    Wijeysundera, Duminda N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (10) : 1116 - 1139
  • [7] Dual Antiplatelet Therapy for Coronary Artery Disease
    Lee, Cheol Whan
    CIRCULATION JOURNAL, 2015, 79 (02) : 255 - 262
  • [8] Dual Antiplatelet Therapy in Coronary Artery Disease
    Sharma, Raghav
    Kumar, Prathap
    Prashanth, S. P.
    Belagali, Yogesh
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 349 - 361
  • [9] What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?
    Otieno, Beryl
    Ibecheozor, Chukwuka
    Williams, Marlene S. S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (07) : 343 - 350
  • [10] What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?
    Beryl Otieno
    Chukwuka Ibecheozor
    Marlene S. Williams
    Current Atherosclerosis Reports, 2023, 25 : 343 - 350
12345